{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:35:00Z","timestamp":1761129300609},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.trsl.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T18:03:04Z","timestamp":1452535384000},"page":"86-97","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Transgenerational transmission of systemic mast cell activation disease\u2014genetic and epigenetic features"],"prefix":"10.1016","volume":"174","author":[{"given":"Gerhard J.","family":"Molderings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2016.01.001_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-8722-4-10","article-title":"Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options","volume":"4","author":"Molderings","year":"2011","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.trsl.2016.01.001_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5315\/wjh.v3.i1","article-title":"A concise, practical guide to diagnostic assessment for mast cell activation disease","volume":"3","author":"Afrin","year":"2014","journal-title":"World J Hematol"},{"key":"10.1016\/j.trsl.2016.01.001_bib4","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood-2004-07-2639","article-title":"Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen","volume":"105","author":"Kohno","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.001_bib5","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1182\/blood-2008-08-175190","article-title":"Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs","volume":"114","author":"Aichberger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.001_bib6","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1038\/cddis.2010.20","article-title":"Pro-apoptotic Bax is the major and Bak an auxiliary effector in cytokine deprivation-induced mast cell apoptosis","volume":"1","author":"Karlberg","year":"2010","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2016.01.001_bib7","doi-asserted-by":"crossref","first-page":"e1906","DOI":"10.1371\/journal.pone.0001906","article-title":"Phenotypic and genotypic characteristics of mastocytosis according to the age of onset","volume":"3","author":"Lanternier","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.01.001_bib8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish network on mastocytosis in a series of 145 patients","volume":"124","author":"Escribano","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib9","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib10","doi-asserted-by":"crossref","unstructured":"Merante S, Magliacane D, Neri I et\u00a0al. The New Italian Mastocytosis Registry. 53rd ASH Annual Meeting and Exposition 2010, Poster 3805, http:\/\/ash.confex.com\/ash\/2010\/webprogram\/Paper28567.html","DOI":"10.1182\/blood.V116.21.3805.3805"},{"key":"10.1016\/j.trsl.2016.01.001_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2567.2012.03627.x","article-title":"Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics","volume":"137","author":"Haenisch","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.trsl.2016.01.001_bib12","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jaci.2012.10.015","article-title":"Prevalence of indolent systemic mastocytosis in a Dutch region","volume":"131","author":"van Doormaal","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of systemic mastocytosis in Denmark","volume":"166","author":"Cohen","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2016.01.001_bib14","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.001_bib15","doi-asserted-by":"crossref","first-page":"e76241","DOI":"10.1371\/journal.pone.0076241","article-title":"Familial occurrence of systemic mast cell activation disease","volume":"8","author":"Molderings","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.01.001_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/205873920601900102","article-title":"Fibromyalgia\u2014new concepts of pathogenesis and treatment","volume":"19","author":"Lucas","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.trsl.2016.01.001_bib17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10067-010-1474-7","article-title":"Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients","volume":"29","author":"Blanco","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.trsl.2016.01.001_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3109\/s10165-012-0679-9","article-title":"A case of fibromyalgia syndrome with anaphylaxis induced by intradermal injection of purified protein derivative","volume":"23","author":"Maeshima","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.trsl.2016.01.001_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00365520410009410","article-title":"Pathogenesis of irritable bowel syndrome: the mast cell connection","volume":"40","author":"Santos","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.001_bib20","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/gut.2010.213108","article-title":"The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome","volume":"59","author":"Klooker","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2016.01.001_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0029-1245707","article-title":"Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome","volume":"49","author":"Frieling","year":"2011","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.001_bib22","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","article-title":"Demonstration of an aberrant mast cell population with clonal markers in a subset of patients with \u201cidiopathic\u201d anaphylaxis","volume":"110","author":"Akin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.001_bib23","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/cea.12369","article-title":"The presence of mast cell clonality in patients with unexplained anaphylaxis","volume":"44","author":"G\u00fclen","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trsl.2016.01.001_bib24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11882-014-0450-8","article-title":"Anaphylaxis as a clinical manifestation of clonal mast cell disorders","volume":"14","author":"Matito","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.trsl.2016.01.001_bib25","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2008.09.043","article-title":"The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project","volume":"122","author":"Decker","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib26","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jaci.2008.10.019","article-title":"Anaphylaxis epidemic: fact or fiction?","volume":"122","author":"Simons","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib27","first-page":"71","article-title":"The epidemiology of irritable bowel syndrome","volume":"6","author":"Canavan","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.trsl.2016.01.001_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.leukres.2005.08.015","article-title":"A novel K5091 mutation of KIT identified in familial mastocytosis\u2014in\u00a0vitro and in\u00a0vivo responsiveness to imatinib therapy","volume":"30","author":"Zhang","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.trsl.2016.01.001_bib29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2005.06.060","article-title":"Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis","volume":"129","author":"Hartmann","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2016.01.001_bib30","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jaci.2012.04.013","article-title":"Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations","volume":"130","author":"Broesby-Olsen","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jaci.2012.11.040","article-title":"Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis","volume":"131","author":"Zanotti","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib32","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jaci.2014.06.007","article-title":"Familial hypertryptasemia with associated mast cell activation syndrome","volume":"134","author":"Sabato","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib33","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jaci.2013.11.039","article-title":"Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities","volume":"133","author":"Lyons","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib34","doi-asserted-by":"crossref","first-page":"S300","DOI":"10.2310\/6650.2005.00006.266","article-title":"Familial cases of mast cell diseases [abstract]","volume":"53","author":"Burks","year":"2005","journal-title":"J Investig Med"},{"key":"10.1016\/j.trsl.2016.01.001_bib35","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00251-010-0474-8","article-title":"Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects","volume":"62","author":"Molderings","year":"2010","journal-title":"Immunogenetics"},{"key":"10.1016\/j.trsl.2016.01.001_bib36","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-kit catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.trsl.2016.01.001_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.trsl.2016.01.001_bib38","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1210\/en.2003-0063","article-title":"High levels of intrauterine corticotropin-releasing hormone, urocortin, tryptase, and interleukin-8 in spontaneous abortions","volume":"144","author":"Madhappan","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.trsl.2016.01.001_bib39","doi-asserted-by":"crossref","first-page":"e14409","DOI":"10.1371\/journal.pone.0014409","article-title":"Estradiol and progesterone regulate the migration of mast cells from the periphery to the uterus and induce their maturation and degranulation","volume":"5","author":"Jensen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.01.001_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijoa.2012.10.006","article-title":"Management of a parturient with mast cell activation syndrome","volume":"22","author":"Valap","year":"2013","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.trsl.2016.01.001_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2013.00029","article-title":"Mast cells as novel mediators of reproductive processes","volume":"4","author":"Woidacki","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1028-4559(10)60040-X","article-title":"Mastocytosis in pregnancy","volume":"49","author":"Madendag","year":"2010","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.trsl.2016.01.001_bib43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000321954","article-title":"Clinical impact of pregnancy in mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) in 45 cases","volume":"156","author":"Matito","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib44","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/AOG.0b013e318242d3c5","article-title":"Systemic mastocytosis complicating pregnancy","volume":"19","author":"Watson","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.trsl.2016.01.001_bib45","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1160\/TH11-05-0351","article-title":"Bleeding diathesis in patients with mast cell activation disease","volume":"106","author":"Seidel","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2016.01.001_bib46","first-page":"S66","article-title":"The detection of novel KIT mutations in mastocytosis","volume":"133","author":"Chan","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2016.01.001_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/bjh.13560","article-title":"Concurrent activating KIT mutations in systemic mastocytosis","volume":"173","author":"Lasho","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2016.01.001_bib48","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations","volume":"130","author":"Bodemer","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2016.01.001_bib49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2007.06619.x","article-title":"Recent advances in the understanding of mastocytosis: the role of KIT mutations","volume":"138","author":"Orfao","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2016.01.001_bib50","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1038\/sj.onc.1202939","article-title":"Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts","volume":"18","author":"Caruana","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2016.01.001_bib51","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","article-title":"The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u201catypical\u201d myeloproliferative disorders and myelodysplastic syndromes","volume":"106","author":"Steensma","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.001_bib52","first-page":"1160","article-title":"Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT","volume":"159","author":"Foster","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.trsl.2016.01.001_bib53","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1523-1747.1998.00414.x","article-title":"Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior","volume":"111","author":"Buttner","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2016.01.001_bib54","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.pas.0000138181.89743.7b","article-title":"CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens","volume":"28","author":"Sotlar","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.trsl.2016.01.001_bib55","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1046\/j.1365-2141.1997.d01-2042.x","article-title":"A new c-kit mutation in a case of aggressive mast cell disease","volume":"96","author":"Pignon","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2016.01.001_bib56","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"08","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.001_bib57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0609.2012.01789.x","article-title":"Circulating KIT D816V mutation positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis","volume":"89","author":"Kristensen","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.trsl.2016.01.001_bib58","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/leu.2011.293","article-title":"An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis","volume":"26","author":"Teodosio","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.trsl.2016.01.001_bib59","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1200\/JCO.2012.42.0133","article-title":"Rare germline mutation of KIT with imatinib-resistant multiple GI stromal tumors and mastocytosis","volume":"31","author":"Speight","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trsl.2016.01.001_bib60","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1182\/blood.V122.21.5267.5267","article-title":"Familial mastocytosis: identification of KIT K509I mutation and its in\u00a0vitro sensitivity to imatinib, dasatinib and PK412","volume":"122","author":"de Melo Campos","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.001_bib61","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaci.2013.12.1090","article-title":"Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype","volume":"134","author":"Chan","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib62","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c- Kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"issue":"Suppl.","key":"10.1016\/j.trsl.2016.01.001_bib63","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.jaci.2005.12.500","article-title":"Indolent systemic mastocytosis with germline D816V somatic c-kit mutation evolving to an acute myeloid leukemia","volume":"117","author":"Escribano","year":"2006","journal-title":"J Allery Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.critrevonc.2014.09.001","article-title":"The genetic basis of mast cell activation disease\u2014looking through a glass darkly","volume":"93","author":"Molderings","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.trsl.2016.01.001_bib65","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.18632\/oncotarget.4213","article-title":"Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder","volume":"6","author":"Chatterjee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.trsl.2016.01.001_bib66","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1182\/blood-2011-12-397588","article-title":"In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells","volume":"120","author":"Soucie","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.001_bib67","doi-asserted-by":"crossref","first-page":"e43090","DOI":"10.1371\/journal.pone.0043090","article-title":"Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis","volume":"7","author":"Traina","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.01.001_bib68","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3324\/haematol.2013.095133","article-title":"SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes","volume":"99","author":"Hanssens","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.trsl.2016.01.001_bib69","doi-asserted-by":"crossref","first-page":"e85362","DOI":"10.1371\/journal.pone.0085362","article-title":"ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases","volume":"9","author":"Damaj","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.01.001_bib70","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood-2013-04-496448","article-title":"Comprehensive mutational profiling in advanced systemic mastocytosis","volume":"122","author":"Schwaab","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.001_bib71","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/00365520701245744","article-title":"Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder","volume":"42","author":"Molderings","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.trsl.2016.01.001_bib72","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/jid.2012.394","article-title":"A c-kit mutation in exon 18 in familial mastocytosis","volume":"133","author":"W\u00f6hrl","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2016.01.001_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000096907","article-title":"C-kit Asp-816-Val mutation analysis in patients with mastocytosis","volume":"214","author":"Verzijl","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.trsl.2016.01.001_bib74","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00251-014-0768-3","article-title":"Evidence for contribution of epigenetic mechanisms in the pathogenesis of systemic mast cell activation disease","volume":"66","author":"Haenisch","year":"2014","journal-title":"Immunogenetics"},{"key":"10.1016\/j.trsl.2016.01.001_bib75","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/ejh.12537","article-title":"Reduced DNA methylation and hydroxymethylation in patients with systemic mastocytosis","volume":"95","author":"Leoni","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.trsl.2016.01.001_bib76","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nature09230","article-title":"Epigenetics as a unifying principle inn the aetiology of complex traits and diseases","volume":"465","author":"Petronis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2016.01.001_bib77","doi-asserted-by":"crossref","first-page":"10604","DOI":"10.1073\/pnas.0500398102","article-title":"Epigenetic differences arise during the lifetime of monozygotic twins","volume":"102","author":"Fraga","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.01.001_bib78","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature04674","article-title":"RNA-mediated non-mendelian inheritance of an epigenetic change in the mouse","volume":"441","author":"Rassoulzadegan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2016.01.001_bib79","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/15490","article-title":"Epigenetic inheritance at the agouti locus in the mouse","volume":"23","author":"Morgan","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2016.01.001_bib80","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1073\/pnas.0436776100","article-title":"Transgenerational inheritance of epigenetic states at the murine axin(fu) allele occurs after maternal and paternal transmission","volume":"100","author":"Rakyan","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.01.001_bib81","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1371\/journal.pgen.0020049","article-title":"Dynamic reprogramming of DNA methylation at an epigenetically sensitive allele in mice","volume":"2","author":"Blewitt","year":"2006","journal-title":"PLoS Genet"},{"key":"10.1016\/j.trsl.2016.01.001_bib82","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1126\/science.1179052","article-title":"Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome","volume":"326","author":"Lombardi","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.trsl.2016.01.001_bib83","doi-asserted-by":"crossref","first-page":"15874","DOI":"10.1073\/pnas.1006901107","article-title":"Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors","volume":"107","author":"Lo","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.01.001_bib84","doi-asserted-by":"crossref","first-page":"e8519","DOI":"10.1371\/journal.pone.0008519","article-title":"Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome","volume":"5","author":"Erlwein","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.01.001_bib85","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1186\/1742-4690-7-10","article-title":"Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome","volume":"7","author":"Groom","year":"2010","journal-title":"Retrovirology"},{"key":"10.1016\/j.trsl.2016.01.001_bib86","doi-asserted-by":"crossref","first-page":"c1018","DOI":"10.1136\/bmj.c1018","article-title":"Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: Retrospective analysis of samples from an established cohort","volume":"340","author":"van Kuppeveld","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.trsl.2016.01.001_bib87","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1742-4690-7-57","article-title":"Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States","volume":"7","author":"Switzer","year":"2010","journal-title":"Retrovirology"},{"key":"10.1016\/j.trsl.2016.01.001_bib88","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1182\/blood-2013-02-483792","article-title":"Redefinition of the human mast cell transcriptome by deep-CAGE sequencing","volume":"123","author":"Motakis","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.001_bib89","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3109\/08923970902862284","article-title":"Viral sequence integration into introns of chemokine receptor genes","volume":"31","author":"Panaro","year":"2009","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.trsl.2016.01.001_bib90","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/08923970903150341","article-title":"Chemokine receptor-related viral protein products","volume":"32","author":"Panaro","year":"2010","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.trsl.2016.01.001_bib91","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/08923973.2010.512012","article-title":"An analysis of the human and mouse CXCR5 gene introns","volume":"33","author":"Panaro","year":"2011","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.trsl.2016.01.001_bib92","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/geno.2002.6705","article-title":"A technique for genome-wide identification of differences in the interspersed repeats integrations between closely related genomes and its application to detection of human-specific integrations of HERV-K LTRs","volume":"79","author":"Buzdin","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.trsl.2016.01.001_bib93","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1007\/s00018-004-4206-9","article-title":"Integration target site selection for retroviruses and transposable elements","volume":"61","author":"Wu","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.trsl.2016.01.001_bib94","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ymthe.2004.08.001","article-title":"Insertion of retroviral vectors in NOD\/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns","volume":"10","author":"Laufs","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.trsl.2016.01.001_bib95","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ymthe.2006.03.001","article-title":"Genotoxicity of retroviral integration in hematopoietic cells","volume":"13","author":"Nienhuis","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.trsl.2016.01.001_bib96","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1084\/jem.178.2.403","article-title":"Suppressible and nonsuppressible autocrine mast cell tumors are distinguished by insertion of an endogenous retroviral element (IAP) into the interleukin 3 gene","volume":"178","author":"Hirsch","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2016.01.001_bib97","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1749-6632.2002.tb05951.x","article-title":"A functional genomics approach to Kaposi's sarcoma","volume":"975","author":"Moses","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.trsl.2016.01.001_bib98","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1182\/blood-2008-01-133355","article-title":"MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia","volume":"111","author":"Jongen-Lavrencic","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.001_bib99","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1073\/pnas.0904715106","article-title":"Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression","volume":"106","author":"Khalil","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2016.01.001_bib100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4049\/jimmunol.182.1.433","article-title":"MicroRNA-221-222 regulate the cell cycle in mast cells","volume":"182","author":"Mayoral","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib101","doi-asserted-by":"crossref","first-page":"e26133","DOI":"10.1371\/journal.pone.0026133","article-title":"MiR-221 influences effector functions and actin cytoskeleton in mast cells","volume":"6","author":"Mayoral","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.01.001_bib102","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1128\/MCB.00824-12","article-title":"MiR-146a and NF-kappaB1 regulate mast cell survival and T lymphocyte differentiation","volume":"32","author":"Rusca","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.trsl.2016.01.001_bib103","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00018-011-0786-3","article-title":"MicroRNA-132 targets HB-EGF upon IgE-mediated activation in murine and human mast cells","volume":"69","author":"Moln\u00e1r","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.trsl.2016.01.001_bib104","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1182\/blood-2011-05-353342","article-title":"Regulation of mast cell survival and function by tuberous sclerosis complex 1","volume":"119","author":"Shin","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.001_bib105","doi-asserted-by":"crossref","first-page":"e98139","DOI":"10.1371\/journal.pone.0098139","article-title":"Identification of microRNAs regulating the developmental pathways of bone marrow derived mast cells","volume":"9","author":"Xiang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2016.01.001_bib106","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1182\/blood-2010-07-293548","article-title":"KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation","volume":"117","author":"Lee","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.001_bib107","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.trsl.2016.01.001_bib108","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1398-9995.2010.02477.x","article-title":"Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis","volume":"66","author":"Niedoszytko","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.trsl.2016.01.001_bib109","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaci.2003.07.008","article-title":"Gene expression analysis in mastocytosis reveals a highly consistent profile with candidate molecular markers","volume":"112","author":"D'Ambrosio","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia","volume":"12","author":"Butterfield","year":"1998","journal-title":"Leuk Res"},{"key":"10.1016\/j.trsl.2016.01.001_bib111","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12026-013-8391-1","article-title":"The transcriptome of the human mast cell leukemia cells HMC-1.2: an approach to identify specific changes in the gene expression profile in KitD816V systemic mastocytosis","volume":"56","author":"Haenisch","year":"2013","journal-title":"Immunol Res"},{"key":"10.1016\/j.trsl.2016.01.001_bib112","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.4049\/jimmunol.173.8.5247","article-title":"T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells","volume":"173","author":"Kashiwakura","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib113","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2164-7-210","article-title":"Genome-wide gene expression profiling of human mast cells stimulated by IgE or FcepsilonRI-aggregation reveals a complex network of genes involved in inflammatory responses","volume":"7","author":"Jayapal","year":"2006","journal-title":"BMC Genomics"},{"key":"10.1016\/j.trsl.2016.01.001_bib114","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trsl.2016.01.001_bib115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/ng1342","article-title":"Germline epimutation of mlh1 in individuals with multiple cancers","volume":"36","author":"Suter","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2016.01.001_bib116","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.gde.2008.07.001","article-title":"Transgenerational epigenetic inheritance in health and disease","volume":"18","author":"Whitelaw","year":"2008","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.trsl.2016.01.001_bib117","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1182\/blood-2013-02-451757","article-title":"The myelodysplastic syndrome as a prototypical epigenetic disease","volume":"121","author":"Issa","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2016.01.001_bib118","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2013.03.008","article-title":"Interplay between the cancer genome and epigenome","volume":"153","author":"Shen","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2016.01.001_bib119","doi-asserted-by":"crossref","unstructured":"Abdulkadir H, Grootens J, Kjellander M et\u00a0al. Histone deacetylase inhibitor SAHA mediates epigenetic silencing of KIT D816V mutated systemic mastocytosis primary mast cells and selective apoptosis of mutated mast cells. ASH Annual Meeting (December 5-8, 2015): Abstract\u00a02834.","DOI":"10.1182\/blood.V126.23.2834.2834"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524416000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T20:58:37Z","timestamp":1600030717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524416000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":119,"alternative-id":["S1931524416000025"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2016.01.001","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transgenerational transmission of systemic mast cell activation disease\u2014genetic and epigenetic features","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}